全文获取类型
收费全文 | 71632篇 |
免费 | 4325篇 |
国内免费 | 876篇 |
专业分类
耳鼻咽喉 | 308篇 |
儿科学 | 2830篇 |
妇产科学 | 1656篇 |
基础医学 | 4133篇 |
口腔科学 | 1987篇 |
临床医学 | 13704篇 |
内科学 | 10030篇 |
皮肤病学 | 529篇 |
神经病学 | 4655篇 |
特种医学 | 2271篇 |
外国民族医学 | 5篇 |
外科学 | 12165篇 |
综合类 | 6515篇 |
一般理论 | 4篇 |
预防医学 | 6970篇 |
眼科学 | 631篇 |
药学 | 4360篇 |
75篇 | |
中国医学 | 2267篇 |
肿瘤学 | 1738篇 |
出版年
2023年 | 1157篇 |
2022年 | 1440篇 |
2021年 | 2694篇 |
2020年 | 2642篇 |
2019年 | 5605篇 |
2018年 | 4737篇 |
2017年 | 3174篇 |
2016年 | 1940篇 |
2015年 | 1942篇 |
2014年 | 4260篇 |
2013年 | 4521篇 |
2012年 | 3162篇 |
2011年 | 3418篇 |
2010年 | 2772篇 |
2009年 | 2484篇 |
2008年 | 2558篇 |
2007年 | 2306篇 |
2006年 | 2037篇 |
2005年 | 1712篇 |
2004年 | 1468篇 |
2003年 | 1218篇 |
2002年 | 998篇 |
2001年 | 877篇 |
2000年 | 685篇 |
1999年 | 653篇 |
1998年 | 507篇 |
1997年 | 503篇 |
1996年 | 342篇 |
1995年 | 337篇 |
1994年 | 320篇 |
1993年 | 227篇 |
1992年 | 224篇 |
1991年 | 176篇 |
1990年 | 119篇 |
1989年 | 132篇 |
1987年 | 109篇 |
1986年 | 119篇 |
1985年 | 1090篇 |
1984年 | 1500篇 |
1983年 | 1121篇 |
1982年 | 1226篇 |
1981年 | 1163篇 |
1980年 | 1017篇 |
1979年 | 1092篇 |
1978年 | 1013篇 |
1977年 | 702篇 |
1976年 | 911篇 |
1975年 | 802篇 |
1974年 | 709篇 |
1973年 | 743篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
[目的]探讨胃三针结合健胃舒颗粒治疗脾虚气滞型功能性消化不良的临床疗效。[方法]将43例患者按随机数字表法分为治疗组22例和对照组21例。治疗组采用针刺中脘、足三里、内关,并口服健胃舒颗粒;对照组予枸橼酸莫沙必利口服。共治疗4周,观察和比较两组症状积分、疗效指数、水负荷试验和生活质量(SF-36)得分的差异变化。[结果]治疗组的总有效率为86.36%,与对照组比较差异有统计学意义(P0.05);治疗后两组的症状积分均有下降,水负荷试验得分、生活质量得分均升高,组间比较,治疗组改善更明显,差异有统计学意义(P0.05)。[结论]胃三针结合健胃舒颗粒治疗脾虚气滞型FD症状改善明显,疗效确切,值得临床广泛推广。 相似文献
102.
V. Jenkins I. Solis-Trapala H. Payne M. Mason L. Fallowfield S. May L. Matthews S. Catt 《Clinical oncology (Royal College of Radiologists (Great Britain))》2019,31(2):99-107
Aims
Delaying progression, ameliorating symptoms and maintaining quality of life (QoL) are primary aims of treatment for metastatic castrate-resistant prostate cancer (mCRPC). Real-world rather than clinical trial data about symptoms and side-effects are sparse. In EXTREQOL, patients' QoL, pain and information needs were recorded during treatment.Material and methods
Men with mCRPC from 20 UK cancer centres starting various systemic mCRPC treatments completed QoL, pain and information needs questionnaires at baseline, 3 and 6 months.Results
In total, 132 patients were recruited. Overall QoL declined significantly by 6 months (Functional Assessment of Cancer Therapy-Prostate [FACT-P] mean = –3.89, 95% confidence interval –6.7 to –1.05, P = 0.007; Trial Outcome Index [TOI] analysis mean = –3.10, 95% confidence interval –5.34 to –0.83, P = 0.007). Those who came off novel therapy and remained on luteinising hormone-releasing hormone agonist therapy alone had worse scores than patients receiving concomitant chemotherapy (Prostate Concerns Subscale mean difference = –4.45, 95% confidence interval –7.06 to –1.83, P = 0.001; TOI mean difference = –5.62, 95% confidence interval –10.97 to –0.26, P = 0.040). At 3 and 6 months, men who reported pain at baseline improved (43%, 40%), but for others pain levels remained the same (45%, 42%) or worsened (13%, 18%). Information regarding supportive care was lacking throughout the period of time on the study.Conclusion
Most mCRPC treated patients experience reduced QoL and inadequate pain control. More help with pain management and better information provision regarding supportive care is warranted. 相似文献103.
104.
BackgroundAutoimmune hepatitis is a chronic inflammatory disease, the abnormal immunological function is the main pathogenesis. Interleukin-34 is a newly identified cytokine that shares the same receptor as colony stimulating factor-1.MethodsWe used interleukin-34 knockout and wild-type mice in a Con A-induced hepatitis model and cocultured RAW264.7 macrophage cells with interleukin-34. We then detected associated inflammatory cytokine and chemokine levels to elucidate the role of interleukin-34.ResultsIn this study, we found that the loss of interleukin-34 resulted in higher sensitivity to Con A-induced hepatitis. RAW264.7 macrophage cells were able to differentiate to the M2 phenotype upon interleukin-34 stimulation.ConclusionsWe conclude that interleukin-34 may protect the liver from Con A-mediated hepatitis by driving M2 macrophage polarization and suppressing inflammation. 相似文献
105.
Kenji Takagishi Tetsuya Matsuura Takashi Masatomi Etsuo Chosa Tsuyoshi Tajika Tetsu Iwama Mikihiko Watanabe Toshiro Otani Katsunori Inagaki Hiroyasu Ikegami Mitsuhiro Aoki Toru Okuwaki Yasushi Kameyama Maeda Akira Koji Kaneoka Masaaki Sakamoto Moroe Beppu 《Journal of orthopaedic science》2019,24(4):708-714
BackgroundDespite proposals and guidelines to prevent baseball injuries in young players by societies and organizations, many shoulder and elbow injuries continue to occur among junior high school baseball players. In order to investigate the training conditions of junior high school baseball players and the risk factors for shoulder and elbow pain in the players, we conducted a questionnaire survey among junior high school baseball players throughout the country.MethodsThe questionnaire survey was conducted among junior high school baseball players in September 2016.ResultsA total of 11,134 junior high school baseball players belonging to 495 teams responded to the survey. Among these, 4004 players trained every day of the week and 1151 players played baseball games every month with no off-season. Among 9752 players who did not have shoulder and/or elbow pain in the spring and summer of 2015, 19.2% of players experienced elbow pain over the course of one year, 13.6% of players experienced shoulder pain, and 28.0% complained of shoulder and/or elbow pain. The frequency of elbow pain was more than that of shoulder pain. At risk for shoulder pain were pitchers and catchers and second-year students, while risk factors for elbow pain were playing pitcher and catcher positions, pitching or throwing ≥300 balls per week, playing ≥10 games on average per month and being left-handed.ConclusionRisk factors for shoulder pain were different from those for elbow pain. To prevent elbow pain, coaches should pay attention to pitchers and catchers and left-handed players and not allow players to pitch or throw ≥300 full-power balls per week or participate in ≥10 games per month. They should also pay attention to pitchers and catchers and second-year students to prevent shoulder pain. It is important for coaches to train multiple pitchers and catchers. 相似文献
106.
107.
Stress Testing Versus CT Angiography in Patients With Diabetes and Suspected Coronary Artery Disease
Abhinav Sharma Adrian Coles Nishant K. Sekaran Neha J. Pagidipati Michael T. Lu Daniel B. Mark Kerry L. Lee Hussein R. Al-Khalidi Udo Hoffmann Pamela S. Douglas 《Journal of the American College of Cardiology》2019,73(8):893-902
Background
The optimal noninvasive test (NIT) for patients with diabetes and stable symptoms of coronary artery disease (CAD) is unknown.Objectives
The purpose of this study was to assess whether a diagnostic strategy based on coronary computed tomographic angiography (CTA) is superior to functional stress testing in reducing adverse cardiovascular (CV) outcomes (CV death or myocardial infarction [MI]) among symptomatic patients with diabetes.Methods
PROMISE (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) was a randomized trial evaluating an initial strategy of CTA versus functional testing in stable outpatients with symptoms suggestive of CAD. The study compared CV outcomes in patients with diabetes (n = 1,908 [21%]) and without diabetes (n = 7,058 [79%]) based on their randomization to CTA or functional testing.Results
Patients with diabetes (vs. without) were similar in age (median 61 years vs. 60 years) and sex (female 54% vs. 52%) but had a greater burden of CV comorbidities. Patients with diabetes who underwent CTA had a lower risk of CV death/MI compared with functional stress testing (CTA: 1.1% [10 of 936] vs. stress testing: 2.6% [25 of 972]; adjusted hazard ratio: 0.38; 95% confidence interval: 0.18 to 0.79; p = 0.01). There was no significant difference in nondiabetic patients (CTA: 1.4% [50 of 3,564] vs. stress testing: 1.3% [45 of 3,494]; adjusted hazard ratio: 1.03; 95% confidence interval: 0.69 to 1.54; p = 0.887; interaction term for diabetes p value = 0.02).Conclusions
In diabetic patients presenting with stable chest pain, a CTA strategy resulted in fewer adverse CV outcomes than a functional testing strategy. CTA may be considered as the initial diagnostic strategy in this subgroup. (PROspective Multicenter Imaging Study for Evaluation of Chest Pain [PROMISE]; NCT01174550) 相似文献108.
109.
Hui Fan Xianzhen Jin Chunyan Liao Lina Qiao Wei Zhao 《Pathology, research and practice》2019,215(11):152667
MicroRNAs (miRNAs) have been found to be aberrantly expressed and exert essential roles in the tumorigenesis and progression of gastric cancer (GC). miR-301b-3p has been recognized as a cancer-related miRNA in lung cancer, bladder cancer and hepatocellular carcinoma. However, the function of miR-301b-3p in GC progression and its underlying mechanism have not been studied yet. In this study, we found that miR-301b-3p expression was up-regulated in GC tissues compared to adjacent noncancerous tissues. Furthermore, the elevated levels of miR-301b-3p were detected in GC cell lines (SGC-7901, AGS, MKN-45 and MGC-803) as compared with GES-1 cells. Interestingly, GC tissues from patients with tumor size ≥ 5 cm and advanced tumor stages showed obvious higher levels of miR-301b-3p compared to matched controls. Functionally, miR-301b-3p knockdown prominently inhibited cell proliferation, and induced cell cycle arrest at G1 phase and apoptosis in MGC-803 cells. Meanwhile, ectopic expression of miR-301b-3p conversely regulated these biological behaviors of MKN-45 cells. Next, we found that miR-301b-3p knockdown increased, whereas miR-301b-3p overexpression reduced the expression of zinc finger and BTB domain containing 4 (ZBTB4) in GC cells. Accordingly, luciferase reporter assay identified ZBTB4 as a direct target of miR-301b-3p. ZBTB4 overexpression markedly restrained the growth of MGC-803 cells. More importantly, ZBTB4 silencing partially reversed miR-301b-3p knockdown-induced tumor suppressive effects on MGC-803 cells. In conclusion, we firstly revealed that miR-301-3p was highly expressed in GC and contributed to tumor progression via attenuating ZBTB4, which might provide a novel molecular-targeted strategy for GC treatment. 相似文献
110.